Modulation of antigen processing and presentation by covalently linked complement C3b fragment.

MR Jacquier-Sarlin, FM Gabert, MB Villiers… - …, 1995 - ncbi.nlm.nih.gov
MR Jacquier-Sarlin, FM Gabert, MB Villiers, MG Colomb
Immunology, 1995ncbi.nlm.nih.gov
Ligands such as complement fragments (C3, C4), IgG or alpha 2-macroglobulin, which bind
antigen (Ag) before their uptake by antigen-presenting cells (APC), are likely to modulate the
different steps of Ag processing and presentation. These ligands contribute to internalization
and endosomal targeting of Ag; they also influence its processing and, consequently, the
binding of resulting peptides to major histocompatibility complex (MHC) class II molecules
before presentation to T cells. Complement protein C3 contains, like other members of the …
Abstract
Ligands such as complement fragments (C3, C4), IgG or alpha 2-macroglobulin, which bind antigen (Ag) before their uptake by antigen-presenting cells (APC), are likely to modulate the different steps of Ag processing and presentation. These ligands contribute to internalization and endosomal targeting of Ag; they also influence its processing and, consequently, the binding of resulting peptides to major histocompatibility complex (MHC) class II molecules before presentation to T cells. Complement protein C3 contains, like other members of the alpha 2-macroglobulin family, an intrachain thiolester bond. Conformational alteration or limited proteolysis of C3 into C3b leads to breaking of the thiolester with transient capacity of the revealed carbonyl group to esterify hydroxyl groups of Ag. Ester-linked complexes including tetanus toxin (TT) and C3b were prepared to analyse the influence of bound C3b on TT processing and presentation by APC. Covalent binding of C3b to TT resulted in increased and prolonged stimulation of specific T-cell proliferation. This effect was observed with non-specific B cells, as well as with a TT-specific B-cell clone, as APC. On the other hand, SDS-PAGE analysis of proteolysates of TT or C3b-TT, obtained with endosome/lysosome-enriched subcellular fractions prepared from human Epstein-Barr virus (EBV)-transformed B cells, indicated a delay of TT proteolysis when TT was associated to C3b. Treatment of APC with protease inhibitors, before and during exposure of the cells to Ag, resulted in differences in the inhibition of TT and C3b-TT proteolysis. Using purified cathepsins B and D, we demonstrated that covalent binding of C3b to TT totally abolished TT proteolysis by cathepsin D, while proteolysis by cathepsin B was preserved. This finding and the absence of cathepsin B in endosomes may explain a delay in TT processing when it is associated to C3b. Confirming these data, presentation by formaldehyde-fixed cells of C3b-TT proteolysates showed higher stimulation of specific T-cell clones than formaldehyde-fixed TT proteolysates.
ncbi.nlm.nih.gov